Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression

SARS-CoV-2 infection causes a wide spectrum of disease severity. Identifying the immunological characteristics of severe disease and the risk factors for their development are important in the management of COVID-19. This study aimed to identify and rank clinical and immunological features associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Liam, Dyer, Adam H., Naughton, Aifric, Imangaliyev, Sultan, Dunne, Jean, Kiersey, Rachel, Holden, Dean, Mooney, Aoife, Leavy, Deirdre, Ridge, Katie, Sugrue, Jamie, Aldoseri, Mubarak, Kelliher, Jo Hannah, Hennessy, Martina, Byrne, Declan, Browne, Paul, Bacon, Christopher L., Doyle, Catriona, O’Riordan, Ruth, McLaughlin, Anne-Marie, Bannan, Ciaran, Martin-Loeches, Ignacio, White, Arthur, McLoughlin, Rachel M., Bergin, Colm, Bourke, Nollaig M., O’Farrelly, Cliona, Conlon, Niall, Cheallaigh, Clíona Ní
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973020/
https://www.ncbi.nlm.nih.gov/pubmed/35386227
http://dx.doi.org/10.1016/j.heliyon.2022.e09230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973020/
https://www.ncbi.nlm.nih.gov/pubmed/35386227
http://dx.doi.org/10.1016/j.heliyon.2022.e09230

Ejemplares similares